SEC Form 4 · accession 0001554795-16-000968
IRIS BIOTECHNOLOGIES INC · IRSB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Simon Chin
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Nov 22, 2016
Accepted (ET)
Dec 2, 2016 · 4:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001396238
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 22, 2016 | S | 1,250 | $0.152 | D | 12,823,594 | D | |
| Common Stock | Nov 22, 2016 | S | 21,750 | $0.12 | D | 12,801,844 | D | |
| Common Stock | Nov 22, 2016 | S | 5,650 | $0.1116 | D | 12,796,194 | D | |
| Common Stock | Nov 22, 2016 | S | 10,000 | $0.11 | D | 12,786,194 | D | |
| Common Stock | Nov 28, 2016 | S | 2,500 | $0.12 | D | 12,783,694 | D | |
| Common Stock | Nov 28, 2016 | S | 27,500 | $0.10 | D | 12,756,194 | D | |
| Common Stock | Nov 28, 2016 | S | 11,881 | $0.08 | D | 12,744,313 | D | |
| Common Stock | Nov 29, 2016 | S | 10,000 | $0.091 | D | 12,734,313 | D | |
| Common Stock | Nov 30, 2016 | S | 2,500 | $0.114 | D | 12,731,813 | D | |
| Common Stock | Nov 30, 2016 | S | 10,000 | $0.09 | D | 12,721,813 | D | |
| Common Stock | Dec 1, 2016 | S | 10,000 | $0.114 | D | 12,711,813 | D | |
| Common Stock | Dec 1, 2016 | S | 10,000 | $0.09 | D | 12,701,813 | D | |
| Common Stock | Dec 2, 2016 | S | 1,250 | $0.098 | D | 12,700,563 | D | |
| Common Stock | Dec 2, 2016 | S | 20,000 | $0.08 | D | 12,680,563 | D |
Table II — derivative securities
No Table II lines on this filing.